HIV News and Research

RSS

Nutra Pharma’s Cobroxin pain reliever is "Best New Product" at the ECRM Conference

Nutra Pharma Corp., a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis (MS), has announced today that its recently launched pain reliever, Cobroxin, was selected as the “Best New Product” at the Efficient Collaborative Retail Marketing (ECRM) Conference. Cobroxin was chosen as the award recipient by conference attendees, including several of the leading national retailers.

31 Aug 2009

IDRI signs agreement to use NanoPass' MicronJet microneedle technology for intradermal vaccines

The Infectious Disease Research Institute (IDRI) and NanoPass Technologies Ltd. (NanoPass) today announced they have entered into an agreement whereby IDRI licenses NanoPass' proprietary MicronJet microneedle technology for the intradermal delivery of products against a number of diseases including tuberculosis, HIV, malaria, leishmaniasis and leprosy, among others. The financial details of the agreement are confidential.

31 Aug 2009

High incidence of HIV infection is found among South African gays

New research from UCSF examining HIV among men who have sex with men (MSM) in the township of Soweto in South Africa has found that a third of gay-identified men are infected with HIV.

31 Aug 2009

Pressure on G20 leader to tax financial transactions for aid money intensifies

G20 finance ministers meeting in London next Friday, ahead of a G20 meeting in Pittsburgh, "will face concerted pressure to introduce a tax on financial transactions as a coalition of anti-poverty campaigners aim to force the issue onto the agenda," the Guardian reports.

29 Aug 2009

Also in Global Health news: ARVs in Uganda; Brazil's fight against HIV/AIDS

Zainab Akol, Uganda's AIDS Control Program director, said the health ministry has acquired enough antiretroviral (ARV) drugs to provide treatment for people living with HIV/AIDS until the end of the year, New Vision reports. In addition to 30 tons of drugs, the ministry received at the beginning of August from the Global Fund to Fight AIDS, Tuberculosis and Malaria, it also purchased ARVs worth about $20 million this month, Akol said (Kagolo, 8/27).

29 Aug 2009

HIV subtype D infected patients more likely to develop dementia

Patients infected with a particular subtype of HIV, the virus that causes AIDS, are more likely to develop dementia than patients with other subtypes, a study led by Johns Hopkins researchers shows. The finding, reported in the September Clinical Infectious Diseases, is the first to demonstrate that the specific type of HIV has any effect on cognitive impairment, one of the most common complications of uncontrolled HIV infection.

28 Aug 2009

Former President Bill Clinton to be the keynote speaker at the Annual Speaker Series Luncheon

Chicago House & Social Service Agency, the first organization in the Midwest to provide housing and support for people living with HIV and AIDS, will host their first ever Speaker Series Luncheon on November 11, 2009, welcoming President Bill Clinton as the keynote speaker.

28 Aug 2009

NAT gains importance as traditional testing methods become inadequate

An expanding population of bacterial strains that are drug resistant, including methicillin-resistant Staphylococcus aureus (MRSA), will be the most important justification for nucleic acid-based tests (NAT).

28 Aug 2009

WTN Services and Winetasting Network to be lead corporate sponsors of the Annual AIDS Walk Napa Valley

WTN Services(R) and the Winetasting Network(R) a division of 1-800-Flowers.com(R) have announced they have deepened the commitment to their existing plan of industry partnerships and projects that better the community.

28 Aug 2009

Urine LAM-ELISA's sensitivity of 50.7% in identifying TB disappoints

Urine LAM-ELISA does not appear to be useful as an independent diagnostic test for pulmonary tuberculosis (TB). A trial of the new diagnostic, described in the open access journal BMC Infectious Diseases found that it was only capable of identifying 50.7% of TB cases.

28 Aug 2009

NIMH grants Xhale $1.7 million to develop the SMART medication adherence system for HIV/AIDS therapies

Xhale, Inc. has been awarded a $1.7 million Small Business Innovation Research (SBIR) Phase II grant by the NIH National Institute of Mental Health (NIMH) to continue the development of SMART (Self Monitoring and Reporting Therapeutics), a breath-based medication adherence system for HIV/AIDS therapies.

28 Aug 2009

Town halls: Even tempers prevail in Wisconsin, but not Phoenix

In Eau Claire, Wisconsin, Rep. Ron Kind, D-Wis, encountered something Democrats may have become unaccustomed to: "a fairly even-tempered crowd" at an "intimate" town hall meeting, Roll Call reports. Kind voted against the reform proposal in the House Ways and Means Committee, but defended current incarnations of the overhaul package during a meeting with local business owners and state National Federation of Independent Business representatives.

28 Aug 2009

Also in global health news: NTD study; false cholera cases in Zimbabwe; contaminated water in Kenya; doctor's strike ends

UPI reports on a recent review article in the journal PLoS Neglected Tropical Diseases that analyzed the toll of neglected tropical diseases on populations in sub-Saharan Africa. "Researchers said helminth (parasitic worm) infections account for approximately 85 percent of the neglected tropical diseases, which overall might be equivalent to more than double that caused by tuberculosis and as much as half of the area's malaria disease burden," the news service writes (8/26).

28 Aug 2009

Viral Genetics cautions investors and the public to rely only on its own releases and disclosures

Viral Genetics (Pink Sheets: VRAL), a biotechnology company that develops drug compounds for HIV/AIDS, autoimmune diseases, and cancer, is issuing this announcement in response to a series of press releases distributed by collegestock.com on August 25 and August 26, and an article published on Today's Financial News entitled "TFN Reader Grapevine: There's Something About Viral Genetics, Inc. (VRAL)," on August 25.

27 Aug 2009

EDCTP welcomes proposals for tuberculosis vaccines and HIV/AIDS treatment projects

EDCTP welcomes project proposals as a response to the following calls: Tuberculosis vaccines, HIV/AIDS treatment and Member States Initiated projects.

27 Aug 2009

XenaCare Holdings to market Cobroxin pain reliever drug in U.S.

Nutra Pharma Corp. (OTCBB: NPHC), a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis (MS), has announced today that it has successfully completed a licensing agreement that grants XenaCare Holdings (OTCBB:XCHO) ongoing exclusive United States marketing and distribution rights for Cobroxin in return for meeting specific minimum performance requirements.

27 Aug 2009

Lakewood-Amedex to speed up development of its broad spectrum anti-influenza product into clinical studies

Lakewood-Amedex Inc., (L-A), the anti-infectives biopharmaceutical company developing a unique portfolio of anti-bacterial and anti-viral products including NuBiotics, a novel family of synthetic anti-bacterial compounds, and anti-viral products against hepatitis, HIV and influenza, announced today that it is accelerating development of its broad spectrum anti-influenza product into clinical studies.

27 Aug 2009

BioAlliance Pharma posts revenue of €4.1 million for the first half of 2009

BioAlliance Pharma SA (Paris:BIO) (Euronext Paris – BIO), a company dedicated to the treatment and supportive care of cancer and AIDS patients, today presented its consolidated half-year accounts to June 30, 2009.

27 Aug 2009

US Department of Health funds a project to enhance the quality of care to women of color suffering from HIV/AIDS

Dr. S. Vincent Grasso, a member of the Stevens Healthcare Information Technology Management Advisory Board and Seminar Leader for the Stevens Healthcare Educational Partnership (SHEP), will act as technical lead, solution provider and systems integrator within a nation-wide initiative to enhance the quality of care to women of color suffering from HIV/AIDS. The US Department of Health and Human Services is the funding agency for the project, which will be implemented in urban centers across America.

27 Aug 2009

Largest non-profit HIV/AIDS healthcare provider mourns Senator Kennedy's death

AIDS Healthcare Foundation (AHF), the nation’s largest non-profit HIV/AIDS healthcare provider which now provides treatment and services for more than 100,000 individuals in 21 countries worldwide in the US, Africa, Latin America/Caribbean and Asia, today mourned the passing of Senator Ted Kennedy (D, MA) who died late Tuesday at his home in Hyannis Port, MA.

27 Aug 2009

HIV News and Research

Nutra Pharma’s Cobroxin pain reliever is "Best New Product" at the ECRM Conference

IDRI signs agreement to use NanoPass' MicronJet microneedle technology for intradermal vaccines

High incidence of HIV infection is found among South African gays

Pressure on G20 leader to tax financial transactions for aid money intensifies

Also in Global Health news: ARVs in Uganda; Brazil's fight against HIV/AIDS

HIV subtype D infected patients more likely to develop dementia

Former President Bill Clinton to be the keynote speaker at the Annual Speaker Series Luncheon

NAT gains importance as traditional testing methods become inadequate

WTN Services and Winetasting Network to be lead corporate sponsors of the Annual AIDS Walk Napa Valley

Urine LAM-ELISA's sensitivity of 50.7% in identifying TB disappoints

NIMH grants Xhale $1.7 million to develop the SMART medication adherence system for HIV/AIDS therapies

Town halls: Even tempers prevail in Wisconsin, but not Phoenix

Also in global health news: NTD study; false cholera cases in Zimbabwe; contaminated water in Kenya; doctor's strike ends

Viral Genetics cautions investors and the public to rely only on its own releases and disclosures

EDCTP welcomes proposals for tuberculosis vaccines and HIV/AIDS treatment projects

XenaCare Holdings to market Cobroxin pain reliever drug in U.S.

Lakewood-Amedex to speed up development of its broad spectrum anti-influenza product into clinical studies

BioAlliance Pharma posts revenue of €4.1 million for the first half of 2009

US Department of Health funds a project to enhance the quality of care to women of color suffering from HIV/AIDS

Largest non-profit HIV/AIDS healthcare provider mourns Senator Kennedy's death

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News